Convalescent plasma (COVID-19) Uses, Dosage, Side Effects and more
Convalescent plasma (COVID-19) is plasma collected from patients who have acquired and subsequently recovered from COVID-19 and which contains antibodies against the causative agent SARS-CoV-2. This investigational COVID-19 treatment is currently available through three main pathways: use in registered clinical trials, use through the expanded access COVID-19 protocol (21 CFR 312.305), and use for single patients through an emergency IND (eIND; 21 CFR 312.310).
Although there are no formal clinical trial results for the safety or efficacy of Convalescent plasma (COVID-19), early results from 5000 patients under the FDA expanded access program suggest that convalescent plasma transfusion in COVID-19 patients is safe.
| Attribute | Details |
|---|---|
| Trade Name | Convalescent plasma (COVID-19) |
| Generic | COVID-19 convalescent plasma |
| COVID-19 convalescent plasma Other Names | Convalescent plasma (COVID-19) |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
